Skip to main content
Premium Trial:

Request an Annual Quote

Almaden Genomics: David Gascoigne

Almaden Genomics, an IBM Research bioinformatics spinoff, has appointed David Gascoigne as CEO. Gascoigne joins the company from Sutherland Global Services where he was head of healthcare analytics. Prior to that he was chief operating officer of GNS Healthcare. He has also served as general manager of analytics services for Iqvia and executive VP of analytics and innovation for Symphony Health; and was a partner in digital analytics with Accenture. He holds an advanced degree in applied statistics from Sheffield University.